Stay Updated with the Latest TKMS AG & Co KGaA TKMS.DE News in Real Time
Find TKMS.DE news now at Meyka AI. Stay informed with the latest TKMS AG & Co KGaA stocks updates, including price news, market analysis, and expert insights.
Canada’s Submarine Fleet Decision Nears End of June, June 01
Canada evaluates submarine bids from Hanwha Oceans and TKMS, with final decision expected by June 2026.
Mutares Stock May 24: New Bond & Portfolio Shake-Up
Mutares stock news: Bond issuance and portfolio updates drive investor attention on May 24.
Thyssenkrupp Stock May 23: Government Stake Fuels Rally
Thyssenkrupp stock rallies as German defense ministry considers stake in TKMS marine division. Steel IPO replaces Jindal sale talks.
Mutares Stock May 23: New Bond & Portfolio Shake-Up
Mutares SE: German turnaround holding announces bond issuance and portfolio updates. Buy-and-build strategy continues ahead of shareholder meeting.
HORNBACH Holding AG & Co. KGaA Climbs 1.79% on Steady Earnings
HBH.DE stock rises 1.79% after reporting €6.43B sales growth and stable dividend despite higher costs and weak German construction demand.
HORNBACH Holding AG Stock Slips 0.25% as DIY Retailer Awaits Earnings
HBH.DE stock falls 0.25% to €78.30 on XETRA. DIY retailer faces earnings announcement May 19. Meyka AI rates stock B+ with Buy recommendation.
MRK.DE Merck KGaA Earnings Beat: EPS Tops Estimates
Merck KGaA beats EPS estimates with $2.08 actual vs $1.97 expected. Revenue misses slightly at $5.05B. Stock up 6.6%.
European Stocks Rise on Tech Rally; Investors Eye Middle East Events
European Stocks moved higher as investors returned to technology and mining shares following a weak previous trading session. The pan European STOXX 600 index closed 0.8% higher at 611.42 points after falling nearly 1% earlier in the week. The recovery was supported by strong gains in technology companies, mining firms, and improving corporate earnings expectations…
Fresenius SE & Co. KGaA Tumbles 32.4% as Healthcare Giant Faces Valuation Pressure
FRE.SW stock crashes 32.4% in pre-market trading. Healthcare specialist faces valuation headwinds amid weak technical signals and analyst downgrades.